U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07072611) titled 'Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants' on June 16.

Brief Summary: The goal of this study is to investigate the safety and tolerability of the topical application of SOF-SKN in healthy volunteers. The study will be divided into part 1 and part 2.

Part 1, is a single ascending dose (SAD) design, while Part 2 is a multiple ascending dose (MAD) design.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Cutaneous Lupus Erythematosus

Intervention: DRUG: SOF-SKN 0.25%

cream for topical application

DRUG: SOF-SKN 0.5%

cream for topical application

D...